COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab
Eva María Fernández-Diaz, Julia Gracia Gil, José Gregorio García-García, María Palao, Carlos Sánchez, Tomás Segura
Abstract
Open-access reader
Eva María Fernández-Diaz, Julia Gracia Gil, José Gregorio García-García, María Palao, Carlos Sánchez, Tomás Segura
Abstract
Open-access reader
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Alemtuzumab, Multiple sclerosis, Medicine, Coronavirus disease 2019 (COVID-19), Immunosuppression, Relapsing remitting, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak